Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial
scientific article published on 01 July 2020
Author/s
author: Joseph D. Khoury, Naveen Pemmaraju, Richard E Champlin, Guillermo Garcia-Manero, Issa F Khouri, Marina Konopleva, Elias Jabbour, Jeffrey C. Jorgensen, Maria R Khouri, Nicholas J. Short, Tapan M Kadia, Courtney D DiNardo, Ghayas C Issa, Partow Kebriaei, Hagop Kantarjian, Naval Daver, Xuelin Huang, Susan O'Brien, Charles G. Mullighan, Koji Sasaki, Srdan Verstovsek, Keyur P Patel
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.